Leerink Initiates Coverage of Exact Sciences With Outperform Rating

NEW YORK (GenomeWeb) – Leerink on Monday initiated coverage of molecular diagnostics firm Exact Sciences with an Outperform rating and a 12-month $30 price target on the company’s stock price.

Get the full story This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
.

Be the first to comment

Leave a Reply

Your email address will not be published.


*